Moderna – Moderna Files for Authorization of Its COVID-19 Vaccine in Young Children Six Months to Under Six Years of Age – Moderna Investor Relations
Submission to Regulators Globally Is Based on Phase 2/3 Studies of mRNA-1273 in Young Children CAMBRIDGE, MA / ACCESSWIRE / April 28, 2022 / Moderna,…